Search Results
Oct 22, 2025, 16:15 ET Ardmore Shipping Announces Third Quarter 2025 Conference Call and Webcast
HAMILTON, Bermuda, Oct. 22, 2025 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its third quarter earnings before the market opens Wednesday, November
More news about: Ardmore Shipping Corporation
Oct 21, 2025, 15:00 ET Second Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS In Recommending Core Scientific Shareholders Vote "AGAINST" Proposed Sale to CoreWeave on GOLD Proxy Card
[email protected](212) 750-5833 MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230
More news about: Two Seas Capital
Oct 21, 2025, 09:05 ET Leading Proxy Advisory Firm Institutional Shareholder Services Recommends Core Scientific Shareholders Vote "AGAINST" Sale to CoreWeave on GOLD Proxy Card
[email protected](212) 750-5833 MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230
More news about: Two Seas Capital
Oct 21, 2025, 08:00 ET 3Gen Consulting and Commit Services Partner to Expand Specialty RCM Expertise and Technology for U.S. Healthcare Providers
into a strategic partnership with Commit Services Inc., a Wilmington, Delaware-based company recognized for its expertise in ambulatory surgery center (ASC) and
More news about: 3Gen Consulting
Oct 20, 2025, 10:00 ET PayrHealth and DocSpera Announce Strategic Partnership to Help Ambulatory Surgery Centers Meet New CMS Requirements and Improve Patient Outcomes
enhance patient engagement. Automate reporting directly to CMS, ensuring compliance while reducing the administrative burden on ASC staff. Leverage outcome data for quality benchmarking to strengthen negotiations with commercial payors.
More news about: PayrHealth
Oct 19, 2025, 20:10 ET 歌禮完成小分子GLP-1R激動劑ASC30治療肥胖症的每月一次皮下儲庫型治療制劑的美國IIa期研究受試者入組
關 於 ASC30 ASC30是一款正在臨床研究中的小分子GLP-1R偏向激動劑，具有獨特和差異化性質，使得同一小分子同時適用於口服片劑和皮下注射給藥成為可能。ASC30是一種新化學實體（NCE），擁有美國和全球化合物專利保護，專利保護期至2044年（不含專利延期）。 關
More news about: 歌禮製藥有限公司
Oct 19, 2025, 20:10 ET Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
About ASC30 ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical
More news about: Ascletis Pharma Inc.
Oct 17, 2025, 12:04 ET Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave
[email protected](212) 750-5833 MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230
More news about: Two Seas Capital
Oct 16, 2025, 16:30 ET Simmons First National Corporation Reports Third Quarter 2025 Results
(1) The Company has elected to use the CECL transition provision allowed for in the year of adopting ASC 326.
More news about: Simmons First National Corporation
Oct 15, 2025, 09:00 ET GTIS Brazil Funds Top GRESB Sustainability Ranking in Latin America
Contacts: GTIS Partners Mary Beth Grover / Keely GispanASC Advisors(203) [email protected]
More news about: GTIS Partners
Oct 14, 2025, 14:07 ET BGL Announces the Sale of the Garden State Medical Center Real Estate Portfolio
Manchester Surgery Center, GSMC's state-of-the-art ambulatory surgery center (ASC). The center includes four private pre-op areas, four PACU beds, four Phase 2 Recovery areas, and two operating rooms. The multi-specialty ASC is equipped for a range of surgical specialties. Founded
More news about: Brown Gibbons Lang & Company
Oct 14, 2025, 06:00 ET 歌禮與中國國家藥品監督管理局完成地尼法司他（ASC40）的新藥上市申請前溝通
期研究中，地尼法司他（ ASC40 ）達到所有主要、關鍵次要及次要療效終點（意向治療集（ ITT ）分析），與安慰劑相比顯著改善中重度尋常性痤瘡。地尼法司他（ ASC40 ）顯示出了良好的安全性與耐受性特徵。所有與地尼法司他（
More news about: 歌禮製藥有限公司
Oct 14, 2025, 06:00 ET Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. All denifanstat (ASC40)-related treatment-emergent adverse events (TEAEs) were mild (Grade 1) or moderate (Grade 2). There were no denifanstat (ASC40)-related Grade 3 or 4 TEAEs and no denifanstat (ASC40)-related serious adverse
More news about: Ascletis Pharma Inc.
Oct 13, 2025, 09:00 ET Two Seas Capital Publishes Investor Presentation Describing Why It Opposes Core Scientific's Proposed Sale to CoreWeave
[email protected](212) 750-5833 MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230
More news about: Two Seas Capital
Oct 12, 2025, 20:10 ET Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development
Therefore, the observed half-life of ASC35 in humans may be predicted to be 30 days or longer based on NHP studies. These preclinical data support ASC35 as a once-monthly treatment for obesity in humans. The longer observed half-life and a flatter pharmacokinetic profile of ASC35 in NHPs compared to other peptide
More news about: Ascletis Pharma Inc.
Oct 08, 2025, 08:47 ET COMPASS SURGICAL PARTNERS TAPS GROWTH-FOCUSED CFO JOHN HAMMACK TO DRIVE ASC PARTNER SUCCESS
high-performing ambulatory surgery center (ASC) networks. For physician partners, Compass delivers proven pathways to ASC ownership, operational excellence, and long-term value. Health systems rely on Compass to scale surgical care efficiently — advancing ASC growth within core service areas and reaching
More news about: Compass Surgical Partners
Oct 08, 2025, 07:55 ET LuminaData Unveils GAAP & SOX-Trained AI Agents Achieving 99.8% Reconciliation Accuracy
Lease Accounting Agent - Simplifies ASC 842 and IFRS 16 compliance by extracting lease data and generating amortization schedules and compliant reports.
More news about: LuminaData
Oct 07, 2025, 12:00 ET TELEO CAPITAL PORTFOLIO COMPANY, SOFTRAX, ACQUIRES BLULOGIX
Virginia, BluLogix's data-driven platform enables businesses to grow recurring revenue models while ensuring compliance with financial regulations such as ASC 606 and IFRS 15. The company's flagship BluIQ platform supports over 100 companies across SaaS, IoT, and other subscription-based industries, offering
More news about: TELEO Capital Management, LLC
Oct 07, 2025, 11:25 ET Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
driven, long-term approach, investing in U.S. equities. Contacts ASC AdvisorsTaylor [email protected] 992 1230
More news about: Defender Capital
Oct 02, 2025, 09:51 ET USOP Names Johnson & Johnson Its Official Vendor for Total Joint Products
orthopedic practices across the Southeast to deliver operational excellence, clinical innovation, and improved patient outcomes and access. USOP supports ASC development, practice growth, and data-driven performance improvement to help practices thrive in an evolving healthcare landscape. Learn more at
More news about: U.S. Orthopaedic Partners
Oct 01, 2025, 10:06 ET NorthStar Anesthesia Expands ASC Partnerships Across Georgia, Showcasing a Scalable Model for Ambulatory Excellence
Oct. 1, 2025 /PRNewswire/ -- NorthStar Anesthesia today announced the expansion of its ambulatory surgery center (ASC) partnerships across Georgia, strengthening its position as a leader in delivering high-quality anesthesia care at scale. With more than 60 active partnerships
More news about: NorthStar Anesthesia
Oct 01, 2025, 08:31 ET Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US
RemeOs™ eligible for separate pass-through payment under both the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system, providing incremental reimbursement for Medicare patients. RemeOs™ is the first and only osteopromotive absorbable
More news about: Bioretec
Oct 01, 2025, 08:26 ET Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US
RemeOs™ eligible for separate pass-through payment under both the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) payment system, providing incremental reimbursement for Medicare patients. RemeOs™ is the first and only osteopromotive absorbable
More news about: Bioretec
Oct 01, 2025, 08:00 ET Newest surgical robot used for total joint replacement surgery for first time in Illinois
surgery center (ASC) using the Stryker Mako 4 surgical robot. Dr. Lake is a fellowship-trained and board-certified orthopedic surgeon, and a partner at Suburban Orthopaedics. He has performed hundreds of robot-assisted hip and knee replacements in hospital and ASC settings and now
More news about: Ashton Center for Day Surgery
Sep 30, 2025, 11:00 ET American Staffing Association Honors Top Social Responsibility Programs in Staffing and Recruiting
Honorable Mentions Advance Sourcing Concepts LLC, "Hope Starts With ASC"Cuready Healthcare Staffing, "Cuready Cares FAME Partnership"Hatch Staffing Services, "HatchLIFE/Ignite Hope"
More news about: American Staffing Association